10.1002/jhet.5570320504
The research focuses on the synthesis of new cyclic compounds, specifically arylethanolamine derivatives, with potential beta-adrenergic agonist selectivity. These compounds are associated with thermogenesis and regulation of insulin release, and their synthesis involves creating oxazolidine, oxazolidin-2-one, and perhydro-1,4-oxazine derivatives. The study aims to develop new potential beta-adrenergic agonists that could be useful in treating obesity due to their lipid mobilization and thermogenic activities with fewer undesirable effects than other lipolytic substances. 2-amino-1-(3-chlorophenyl)-1-ethanol plays a crucial role as a key starting material for the synthesis of the oxazolidine derivatives. It is used to form the core structure of the target compounds through cyclization reactions. Specifically, it is reacted with formaldehyde under reflux conditions to form the oxazolidine ring, which is a fundamental part of the cyclic compounds being synthesized. This compound is essential for introducing the chlorophenyl and amino groups into the structure, which are critical for the potential beta-adrenergic agonist activity of the final products.